CNXC.NASDAQConcentrix CORP

8-K: Concentrix Exceeds Q1 Revenue and Profit Guidance, Reaffirms Full-Year Outlook

Sentiment:

Earnings Release


Concentrix Corporation reports strong first quarter results, exceeding revenue and profit guidance, and reiterates its full-year fiscal 2025 outlook.

Better than expectedThe company exceeded its first quarter revenue and profit guidance.

Summary

  • Concentrix Corporation (CNXC) announced its financial results for the first quarter ended February 28, 2025.
  • Revenue for the quarter was $2,372.2 million, a 1.3% decrease year-over-year, but grew 1.3% on a constant currency basis.
  • Operating income increased to $168.9 million, or 7.1% of revenue, compared to $148.4 million, or 6.2% of revenue, in the prior year.
  • Non-GAAP operating income was $321.5 million, or 13.6% of revenue, compared to $319.1 million, or 13.3% of revenue, in the prior year.
  • Adjusted EBITDA was $374.2 million, or 15.8% of revenue, compared to $384.3 million, or 16.0% of revenue, in the prior year.
  • Diluted earnings per share (EPS) was $1.04, compared to $0.76 in the prior year.
  • Non-GAAP diluted EPS was $2.79, compared to $2.57 in the prior year.
  • The company expects to generate approximately $625 million to $650 million of adjusted free cash flow in fiscal year 2025.
  • Concentrix expects to return more than $240 million to shareholders in fiscal 2025 through share repurchases and dividends.
  • For the second quarter of fiscal 2025, the company expects revenue between $2.370 billion and $2.390 billion and non-GAAP EPS of $2.69 to $2.80.
  • For the full year fiscal 2025, the company expects revenue between $9.490 billion and $9.635 billion and non-GAAP EPS of $11.18 to $11.77.

Sentiment

Score: 8

Explanation: The document presents a positive outlook with exceeded guidance and reaffirmed full-year expectations. While revenue growth is slightly down year-over-year, the company is managing costs effectively and focusing on growth areas like GenAI.

Positives

  • The company exceeded its first quarter revenue and profit guidance.
  • Operating income increased by 13.8% year-over-year.
  • Diluted earnings per share (EPS) increased to $1.04 compared to $0.76 in the prior year.
  • The company expects to generate $625 million to $650 million of adjusted free cash flow in fiscal year 2025.
  • Concentrix expects to return more than $240 million to shareholders in fiscal 2025 through share repurchases and dividends.
  • The Board of Directors has declared a quarterly dividend of $0.33275 per share payable on May 6, 2025.

Negatives

  • Revenue decreased by 1.3% year-over-year as reported.
  • Adjusted EBITDA decreased by 2.6% year-over-year.
  • Adjusted free cash flow was a use of $39.8 million in the quarter.

Risks

  • General economic conditions and their effects on clients' businesses, including consumer demand, interest rates, and inflation.
  • Cyberattacks on the company's or its clients' networks and information technology systems.
  • Uncertainty around new and emerging technologies, including the adoption and utilization of generative artificial intelligence.
  • Failure of staff and contractors to adhere to the company's and its clients' controls and processes.
  • Inability to protect personal and proprietary information.
  • Geopolitical, economic, and climate-related risks in regions with a significant concentration of the company's operations.
  • Variability in demand by the company's clients or the early termination of the company's client contracts.
  • Currency exchange rate fluctuations.

Future Outlook

The company provides guidance for the second quarter and full year fiscal 2025, including revenue, operating income, and non-GAAP EPS expectations. They anticipate constant currency revenue growth and adjusted free cash flow generation.

Management Comments

  • Our first quarter results demonstrate our progress as we win quality business and take advantage of GenAI opportunities, leveraging our unique technology and service capabilities to drive our clients success, said Chris Caldwell, President and CEO of Concentrix.
  • With a solid start to the year, we remain on track to deliver ongoing constant currency revenue growth, while expanding margins and growing free cash flow in 2025 and beyond.

Industry Context

Concentrix is positioning itself to capitalize on the growing demand for integrated technology and service solutions, particularly in areas like GenAI. The company's focus on end-to-end solutions and its global presence allows it to serve a diverse range of clients across various industries.

Comparison to Industry Standards

  • Concentrix's adjusted EBITDA margin of 15.8% is comparable to other major players in the customer experience (CX) and business process outsourcing (BPO) industry.
  • Companies like Teleperformance and Sitel Group typically report adjusted EBITDA margins in the range of 14-17%.
  • Concentrix's focus on technology and AI-driven solutions aligns with the industry trend of leveraging automation and analytics to improve efficiency and customer outcomes.

Stakeholder Impact

  • Shareholders will benefit from the company's share repurchase program and dividend payments.
  • Clients will benefit from the company's focus on technology and AI-driven solutions.
  • Employees may benefit from the company's growth and expansion in areas like GenAI.

Next Steps

  • The company will host a conference call for investors to review its first quarter fiscal 2025 results.
  • The Board of Directors has declared a quarterly dividend of $0.33275 per share payable on May 6, 2025.

Key Dates

DateDescription
February 11, 2025Company paid a $0.33275 per share quarterly dividend.
February 28, 2025End of the fiscal first quarter.
April 25, 2025Shareholders of record date for the next quarterly dividend.
May 6, 2025Date of payment for the next quarterly dividend of $0.33275 per share.
May 31, 2025End of the second quarter forecast period.
November 30, 2025End of the full year forecast period.

Keywords

financial results, first quarter, revenue, earnings, guidance, Concentrix, CNXC

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.